CTRI/2021/06/034237已完成未知
Drug utilization patterns of proton pump inhibitors in acid pepticdisease patients with co-morbidities in India: A real-worldelectronic medical records-based study
试验速览
- 阶段
- 未知
- 状态
- 已完成
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •1. Patients aged >=18 years
- •2. Patients on PPI therapy for APD along with comorbidities which
- •include endocrinological, neurological, gynaecological, cardiovascular, chronic infectious diseases, orthopedics and renal
- •comorbidities
- •3. Patients with at least two visits to the clinic after the baseline visit
- •will be included
排除标准
- •1. Incomplete records of the patients (i.e., records not fulfilling the abovementioned
- •inclusion criteria) will be excluded
研究者
相似试验
已完成
不适用
The Use of Proton Pump Inhibitors in General PracticeDigestive system diseases: Peptic ulcer diseaseDigestive SystemPeptic ulcerISRCTN70358598HS R&D Regional Programme Register - Department of Health (UK)
进行中（未招募）
1 期
Pharmacokinetics of Proton Pump Inhibitors in a random Icelandic PopulatioGastro Oesophageal Reflux DiseaseEUCTR2015-002230-41-ISandspitali University Hospital30
已完成
不适用
The influence of proton pump inhibitor therapy on the clinical course of COVID-19SARS-CoV2J12.8J80.0Other viral pneumoniaDRKS00021523niversitätsklinikum Freiburg, Klinik für Innere Medizin II152
已完成
不适用
Proton pump inhibitors, oral and injectable, in preventing peptic ulcer re-bleedinggastroduodenal ulcer.Peptic ulcer, site unspecifiedIRCT2014082515510N2Vice Chancellor for research of Mazandaran University of Medical Sciences260
尚未招募
不适用
Study of the effect of Proton Pump Inhibitor (PPI) on intra-gastric pH in healthy volunteer - Comparison of Esomeprazole and RabeprazoleGastroesophageal reflux disease(GERD)JPRN-UMIN000014577Shimane University Faculty of Medicine Second Department of Internal Medicine30